Anabolic-androgenic steroids in sport
DOI:
https://doi.org/10.12775/QS.2024.21.54158Keywords
anabolic-androgenic steroids, anabolic-androgenic steroids side effects, anabolic-androgenic steroids dopingAbstract
Introduction and objective
Anabolic-androgenic steroids (AAS) are a group of doping substances. They cause muscle hypertrophy and an increase in strength. Moreover, they may lead to dangerous side effects. Knowledge of the side effects of AAS use is necessary because in clinical practice we often encounter patients who decide to supplement with steroids. The aim of the study is to present information on the epidemiology, mechanism of action, methods of detecting AAS, the impact of the substance on the male and female body, and a description of organ side effects, highlighting: the cardiovascular system, the nervous system and the psyche.
Review methods
Literature search was conducted in the PubMed database with inclusion criteria ‘free full texts’ and publications date between 2015 – 2024. A total of 7272 results were found; 30 publications were ultimately included in the review.
Abbreviated description of the state of knowledge
Overusing AAS is very popular among people training at the gym. They have an anabolic effect on muscle tissue. They contribute to infertility in men and masculinization in women. Stimulation of androgen receptors above physiological doses of AAS leads to vascular changes that, in extreme cases, may lead to sudden cardiac death. Moreover, they accelerate brain aging. An increase in aggression and risky sexual behavior has been observed among people using doping. The diagnostic material used in anti-doping tests is urine and blood serum.
Summary
AAS abuse is a serious public health problem. Men who want to improve their figure and decide to use doping are particularly at risk. Due to the easy availability of steroids, society should be made aware of the negative effects of steroid use.
References
de Ronde W & Smit D. L. (2020). Anabolic androgenic steroid abuse in young males. Endocrine connections, 9(4), R102–R111. https://doi.org/10.1530/EC-19-0557
Heerfordt IM, Windfeld-Mathiasen J, Dalhoff KP et al. (2024). Cutaneous manifestations of misuse of androgenic anabolic steroids: A retrospective cohort study. Journal of the American Academy of Dermatology, 90(5), 1047–1048. https://doi.org/10.1016/j.jaad.2024.01.007
Bond P, Smit D, de Ronde W. Anabolic-androgenic steroids: How do they work and what are the risks? Front Endocrinol (Lausanne). 2022 Dec 19; 13:1059473. https://doi.org/10.3389/fendo.2022.1059473
Ding JB, Ng MZ, Huang SS et al. (2021). Anabolic-Androgenic Steroid Misuse: Mechanisms, Patterns of Misuse, User Typology, and Adverse Effects. Journal of sports medicine (Hindawi Publishing Corporation), 2021, 7497346.
https://doi.org/10.1155/2021/7497346
Ganesan K, Rahman S, Zito P. Anabolic Steroids. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK482418/ (acces 2024.06.17)
García-Arnés J, García-Casares N. Doping and sports endocrinology: anabolic-androgenic steroids. Rev Clin Esp (Barc). 2022 Dec;222(10):612-620. https://doi.org/10.1016/j.rceng.2022.09.003
Albano G, Amico F, Cocimano G, et al. Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review. Healthcare (Basel). 2021 Jan 19;9(1):97. https://doi.org/10.3390/healthcare9010097
Liu J, Wu Y. Anabolic-androgenic steroids and cardiovascular risk. Chin Med J (Engl). 2019 Sep 20;132(18):2229-2236. https://doi.org/10.1097/CM9.0000000000000407
Van-Duyne G, Blair I, Sprenger C, et al. The androgen receptor. Vitam Horm. 2023;123:439-481. https://doi.org/10.1016/bs.vh.2023.01.001
Davey RA & Grossmann M. (2016). Androgen Receptor Structure, Function and Biology: From Bench to Bedside. The Clinical biochemist. Reviews, 37(1), 3–15. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810760/
McCullough D, Webb R, Enright KJ, et al. (2021). How the love of muscle can break a heart: Impact of anabolic androgenic steroids on skeletal muscle hypertrophy, metabolic and cardiovascular health. Reviews in endocrine & metabolic disorders, 22(2), 389–405. https://doi.org/10.1007/s11154-020-09616-y
Patanè FG, Liberto A, Maria Maglitto AN, et al. (2020). Nandrolone Decanoate: Use, Abuse and Side Effects. Medicina (Kaunas, Lithuania), 56(11), 606. https://doi.org/10.3390/medicina56110606
AlShareef S, Gokarakonda S, Marwaha R. Anabolic Steroid Use Disorder. [Updated 2023 Jun 20]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538174/ (access: 2024.06.17)
Grant B, Kean J, Vali N, et al. (2023). The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men. Substance abuse treatment, prevention, and policy, 18(1), 66. https://doi.org/10.1186/s13011-023-00573-8
Elzenaty N, du Toit T, Flück C. Basics of androgen synthesis and action. Best Pract Res Clin Endocrinol Metab. 2022 Jul;36(4):101665. https://doi.org/10.1016/j.beem.2022.101665
Börjesson A, Ekebergh M, Dahl ML, et al. (2021). Women's Experiences of Using Anabolic Androgenic Steroids. Frontiers in sports and active living, 3, 656413. https://doi.org/10.3389/fspor.2021.656413
Huang G, Basaria S. Do anabolic-androgenic steroids have performance-enhancing effects in female athletes? Mol Cell Endocrinol. 2018 Mar 15;464:56-64. https://doi.org/10.1016/j.mce.2017.07.010
Fadah K, Gopi G, Lingireddy A, et al. Anabolic androgenic steroids and cardiomyopathy: an update. Front Cardiovasc Med. 2023 Jul 26;10:1214374. https://doi.org/10.3389/fcvm.2023.1214374
Lemiński A, Kubis M, Kaczmarek K, et al. (2022). When Bodybuilding Goes Wrong-Bilateral Renal Artery Thrombosis in a Long-Term Misuser of Anabolic Steroids Treated with AngioJet Rheolytic Thrombectomy. International journal of environmental research and public health, 19(4), 2122. https://doi.org/10.3390/ijerph19042122
Torrisi M, Pennisi G, Russo I, et al. (2020). Sudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review. Medicina (Kaunas, Lithuania), 56(11), 587. https://doi.org/10.3390/medicina56110587
Momoh R. Anabolic-Androgenic Steroid Abuse Causes Cardiac Dysfunction. Am J Mens Health. 2024 Mar-Apr;18(2):15579883241249647. https://doi.org/10.1177/15579883241249647
Middlebrook I, Schoener B. Anabolic Steroid Toxicity. [Updated 2022 Nov 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544259/ (access: 2024.06.17)
Wenbo Z & Yan Z. (2023). The Uses of Anabolic Androgenic Steroids Among Athletes; Its Positive and Negative Aspects- A Literature Review. Journal of multidisciplinary healthcare, 16, 4293–4305. https://doi.org/10.2147/JMDH.S439384
Hughes D. The World Anti-Doping Code in sport: Update for 2015. Aust Prescr. 2015 Oct;38(5):167-70. https://doi.org/10.18773/austprescr.2015.059
Protti M, Marasca C, Cirrincione M, et al. (2020). Dried Urine Microsampling Coupled to Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) for the Analysis of Unconjugated Anabolic Androgenic Steroids. Molecules (Basel, Switzerland), 25(14), 3210. https://doi.org/10.3390/molecules25143210
Makvandi B, Pohanka A, Bergström M, et al. Detection of anabolic androgenic steroids in serum samples. Drug Test Anal. 2023 Jun;15(6):678-688. https://doi.org/10.1002/dta.3476
Stojko M, Nocoń J, Piłat P, et al. Innovative Reports on the Effects of Anabolic Androgenic Steroid Abuse-How to Lose Your Mind for the Love of Sport. Medicina (Kaunas). 2023 Aug 8;59(8):1439. https://doi.org/10.3390/medicina59081439
Bjørnebekk A, Kaufmann T, Hauger L, et al. Long-term Anabolic-Androgenic Steroid Use Is Associated With Deviant Brain Aging. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 May;6(5):579-589. https://doi.org/10.1016/j.bpsc.2021.01.001
Zitzmann M. (2020). Testosterone, mood, behaviour and quality of life. Andrology, 8(6), 1598–1605. https://doi.org/10.1111/andr.12867
Bertozzi G, Sessa F, Albano GD, et al. (2018). The Role of Anabolic Androgenic Steroids in Disruption of the Physiological Function in Discrete Areas of the Central Nervous System. Molecular neurobiology, 55(7), 5548–5556. https://doi.org/10.1007/s12035-017-0774-1
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Martyna Dutka, Radosław Bernacki, Piotr Bernacki, Witold Zardzewiały, Klaudia Skrzyńska, Oleksii Zaremskyi, Izabela Przybyło, Kamil Fuszara, Krzysztof Mendyk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 337
Number of citations: 0
